Yahoo
NYSE - Delayed Quote USD

Healthcare Realty Trust Incorporated (HR)

18.49 +0.36 (+1.99%)
At close: October 30 at 4:00:03 PM EDT
18.49 0.00 (0.00%)
After hours: October 30 at 5:24:08 PM EDT
Trade HR on Coinbase
HR Q3 2026 earnings call
Replay the call for the latest insights.
Chart Range Bar
Loading chart for HR
  • Previous Close 18.13
  • Open 18.65
  • Bid 18.48 x 600000
  • Ask 19.69 x 450000
  • Day's Range 18.33 - 18.79
  • 52 Week Range 16.31 - 22.04
  • Volume 9,499,331
  • Avg. Volume 4,403,463
  • Market Cap (intraday) 6.416B
  • Beta (5Y Monthly) 0.84
  • PE Ratio (TTM) --
  • EPS (TTM) -0.27
  • Earnings Date Oct 29, 2026
  • Forward Dividend & Yield 0.96 (5.30%)
  • 1y Target Est 21.08
  • Zacks Rating Bullish

Healthcare Realty Trust Incorporated is a real estate investment trust (REIT) that owns and operates medical outpatient buildings primarily located around market-leading hospital campuses. The Company selectively grows its portfolio through property acquisition and development. As of September 30, 2025, the Company was invested in 579 real estate properties in 28 states totaling 33.6 million square feet and had an enterprise value of approximately 11.1 billion dollars, defined as equity market capitalization plus the principal amount of debt less cash. Healthcare Realty Trust Incorporated was incorporated in 1992 and is based in Nashville, United States.

www.healthcarerealty.com

539

Full Time Employees

December 31

Fiscal Year Ends

Real Estate

Sector

Recent News

View More

Performance Overview

Trailing total returns as of 10/30/2026, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .

YTD Return

HR
13.23%
S&P 500 (^GSPC)
10.73%

1-Year Return

HR
9.52%
S&P 500 (^GSPC)
11.11%

3-Year Return

HR
59.20%
S&P 500 (^GSPC)
81.91%

5-Year Return

HR
1.52%
S&P 500 (^GSPC)
64.59%

Earnings Trends

View More

Earnings Per Share

GAAP
Normalized
GAAP
Normalized

Revenue vs. Earnings

Annual
Quarterly
Annual
Quarterly
Q3 FY26
Revenue 286.64M
Earnings -15.76M
Profit Margin -5.50%

Q4

FY25

Q1

FY26

Q2

FY26

Q3

FY26

0
100M
200M
-15.0%
-10.0%
-5.0%
0.0%
5.0%

Analyst Insights

View More

Analyst Price Targets

18.00
21.08 Average
18.49 Current
24.00 High

Analyst Recommendations

  • Strong Buy
  • Buy
  • Hold
  • Underperform
  • Sell

Latest Rating

Date 10/20/2026
Analyst Deutsche Bank
Rating Action Upgrade
Rating Buy
Price Action Raises
Price Target 18 -> 23

Statistics

View More

Valuation Measures

Annual
  • Market Cap

  • Enterprise Value

  • Trailing P/E

  • Forward P/E

  • PEG Ratio (current)

  • Price/Sales (ttm)

  • Price/Book (mrq)

  • Enterprise Value/Revenue

  • Enterprise Value/EBITDA

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    -7.57%

  • Return on Assets (ttm)

    0.86%

  • Return on Equity (ttm)

    -1.92%

  • Revenue (ttm)

    1.15B

  • Net Income Avi to Common (ttm)

    -89.65M

  • Diluted EPS (ttm)

    -0.27

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    24.67M

  • Total Debt/Equity (mrq)

    103.03%

  • Levered Free Cash Flow (ttm)

    493.02M

Company Insights

Research Reports

View More

People Also Watch

Mobilize your Website
View Site in Mobile | Classic
Share by: